LSN-3316612
N/A
Report date: 2025/11/27 17:57:20
NME
Base Information
Drug NameLSN-3316612
Drug Alias Name +[13]
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesNational Institute Of Mental HealthEli Lilly And Company
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A